Carotid stenting for restenosis after endarterectomy

Cardiovasc Intervent Radiol. 2011 Jun;34(3):488-92. doi: 10.1007/s00270-010-0006-9. Epub 2010 Nov 12.

Abstract

Introduction: Restenosis after carotid endarterectomy (CEA) has been described in 8-19% of patients, 14-23% of whom become symptomatic. This study analyzes our experience with carotid artery stenting (CAS) for post-CEA recurrent stenoses.

Method: Retrospective database and case-note review.

Results: Between January 2000 and September 2008, a total of 27 patients (15 symptomatic) with hemodynamically significant internal carotid artery post-CEA restenosis underwent CAS. Median stenosis of target vessels was 90% (range 75-95%). There was one periprocedural death (3.7%); no others occurred during the median 34-month follow-up (range 0.1-84 months). There was one late transient ischemic attack 12 months after CAS that was not associated with in-stent restenosis. One 90% restenosis and one occlusion were detected during follow-up at 38 and 57 months after CAS. The remaining patients had no evidence of further restenosis and remained free from cerebrovascular symptoms.

Conclusion: CAS offers a feasible option for the management of carefully selected patients with symptomatic and asymptomatic restenosis after CEA.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiography
  • Carotid Stenosis / diagnostic imaging
  • Carotid Stenosis / surgery*
  • Endarterectomy, Carotid*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Stents*
  • Treatment Outcome
  • Ultrasonography, Doppler, Duplex

Substances

  • Platelet Aggregation Inhibitors